# Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)

> **NCT00749099** · NA · TERMINATED · sponsor: **Digestive Care, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Exocrine Pancreatic Insufficiency

## Interventions

- **DRUG:** pancrelipase
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00749099
- **Lead sponsor:** Digestive Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** No longer required study by FDA for NDA approval.
- **Last updated:** 2013-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749099, "Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00749099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*